Andersen Eric's Form 4 filing
Merrimack Pharmaceuticals Inc (MACK) · filed Feb 1, 2023
- Accession no.
- 0000899243-23-003115
- Filed
- Feb 1, 2023, 4:05 PM ET
- Trade date
- Jan 30-31, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $306.1K. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0000899243-23-006607 (Mar 1, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Andersen EricCIK 0001517667 | Director, Other: See remarks |
| Western Standard Partners LPCIK 0001450414 | Other: See Remarks |
| Western Standard LLCCIK 0001517666 | Other: See Remarks |
| Western Standard Partners QP, L.P.CIK 0001544857 | Other: See Remarks |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2023 | Common Stock | PPurchaseAcquired | +19,750 | $11.36 | +$224,312.6 | 1,282,853 | Indirect | |
| Jan 30, 2023 | Common Stock | PPurchaseAcquired | +4,958 | $11.36 | +$56,310.98 | 323,856 | Indirect | |
| Jan 31, 2023 | Common Stock | PPurchaseAcquired | +1,782 | $11.40 | +$20,314.44 | 1,284,635 | Indirect | |
| Jan 31, 2023 | Common Stock | PPurchaseAcquired | +450 | $11.40 | +$5,129.91 | 324,306 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.